- Home
- GUTS
GUTS
FRACTYL HEALTH INC
as 11-15-2024 4:00pm EST
Stocks
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $18.00 | AVG Volume (30 days): | 473.8K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.74 - $14.50 | Next Earning Date: | 11-12-2024 |
| Revenue: | $97,000 | Revenue Growth: | -14.16% |
| Revenue Growth (this year): | -87.25% | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of FRACTYL HEALTH INC (GUTS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Caplan Jay David | GUTS | President, Chief Product Off. | Nov 10 '24 | Sell | $2.47 | 64,197 | $158,540.91 | 153,544 | |
| Rajagopalan Harith | GUTS | Chief Executive Officer | Nov 10 '24 | Sell | $2.47 | 96,517 | $238,358.38 | 491,329 | |
| Caplan Jay David | GUTS | President, Chief Product Off. | Sep 12 '24 | Sell | $2.90 | 65,000 | $188,474.00 | 153,544 |
Latest FRACTYL HEALTH INC News
GUTS Breaking Stock News: Dive into GUTS Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023)
GlobeNewswire
5 days ago
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
13 days ago
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
GlobeNewswire
13 days ago
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
GlobeNewswire
19 days ago
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
GlobeNewswire
20 days ago
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
GlobeNewswire
2 months ago
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
GlobeNewswire
2 months ago
Fractyl Health to Participate in Upcoming September Investor Conferences
Compare GUTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GUTS FRACTYL HEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.